These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3588517)

  • 21. [What do we know today about neuroleptic malignant syndrome?].
    Nyquist OG
    Tidsskr Nor Laegeforen; 1996 Oct; 116(24):2879-82. PubMed ID: 8975402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Technic and role of neuroleptic treatment with perphenazine in psychiatry].
    Ropert R
    Psychopharmacologie; 1971; ():71-82. PubMed ID: 5162009
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome.
    Trutia A; Bledowski J; Pandurangi A; Kahn DA
    J Psychiatr Pract; 2008 Nov; 14(6):398-402. PubMed ID: 19057242
    [No Abstract]   [Full Text] [Related]  

  • 24. [Malignant neuroleptic syndrome--a possibility for early diagnosis].
    Rasmussen KT; Scherling A
    Ugeskr Laeger; 1991 Oct; 153(43):3018-9. PubMed ID: 1801391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful management of a patient with neuroleptic malignant syndrome associated with marked elevation of serum creatine kinase.
    Takizawa D; Nishikawa K; Hiraoka H; Hinohara H; Saito S; Goto F; Kunimoto F
    J Anesth; 2004; 18(2):135-7. PubMed ID: 15127263
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of treatment of schizophrenic and schizoaffective patients with sulpiride (Eglonyl Alkaloid) in comparison with perphenazine (Perfenazin Spofa)].
    Svestka J; Rysánek R; Náhunek K; Cesková E
    Cesk Psychiatr; 1990 Jun; 86(3):145-56. PubMed ID: 2225184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Perphenazine enantate in long-term therapy of psychoses].
    Gunby B
    Nord Psykiatr Tidsskr; 1968; 22(4):358-60. PubMed ID: 5710606
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug-responsive symptoms during early neuroleptic treatment.
    Mazure CM; Nelson JC; Jatlow PI; Bowers MB
    Psychiatry Res; 1992 Feb; 41(2):147-54. PubMed ID: 1574541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome.
    Eiser AR; Neff MS; Slifkin RF
    Arch Intern Med; 1982 Mar; 142(3):601-3. PubMed ID: 6121542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome in a patient with head injury.
    Perez-Vela JL; Sanchez Casado M; Sanchez-Izquierdo Riera JA; Ambros Checa A; Caballero Cubedo R; Alted Lopez E
    Intensive Care Med; 1996 Jun; 22(6):593-5. PubMed ID: 8814479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant treatment of neuroleptic malignant syndrome and psychosis.
    Goldwasser HD; Hooper JF; Spears NM
    Br J Psychiatry; 1989 Jan; 154():102-4. PubMed ID: 2775937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All elevated creatine kinase is not neuroleptic malignant syndrome.
    Maniam T; Rahman MA
    Med J Malaysia; 1994 Sep; 49(3):252-4. PubMed ID: 7845275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic malignant syndrome.
    McCarthy A
    Br J Psychiatry; 1989 Jul; 155():127. PubMed ID: 2641996
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
    Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H
    Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effects of Baicalin on Myoglobinuric Acute Renal Failure in Rats.
    Yalçınkaya Yavuz Ö; Aydoğdu N; Taştekin E; Süt N
    Balkan Med J; 2018 Jan; 35(1):68-76. PubMed ID: 28903885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM; Shifrar KA
    Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bitemporal ultra-brief pulse electroconvulsive therapy for the treatment of neuroleptic malignant syndrome in a first psychotic episode: a case report.
    Marcolin KA; Rodrigues CO; Muller TM; Salles FS; Calegaro V; Cunha AB
    Trends Psychiatry Psychother; 2017; 39(1):62-63. PubMed ID: 28403325
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasmapheresis in neuroleptic malignant syndrome.
    Gaitini L; Fradis M; Vaida S; Krimerman S; Beny A
    Anaesthesia; 1997 Feb; 52(2):165-8. PubMed ID: 9059103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine treatment of neuroleptic malignant syndrome.
    Dhib-Jalbut S; Hesselbrock R; Mouradian MM; Means ED
    J Clin Psychiatry; 1987 Feb; 48(2):69-73. PubMed ID: 3804991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome: an underdiagnosed condition.
    Harradine PG; Williams SE; Doherty SR
    Med J Aust; 2001 Jun; 174(11):593-4. PubMed ID: 11453335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.